FCX vs KZR · P/E 38, rev $13.26B vs $53.9M cap
Freeport-McMoran Copper & Gold Inc (FCX) versus Kezar Life Sciences Inc (KZR) — a side-by-side from cached financials, not a winner call.
Freeport-McMoran Copper & Gold Inc (FCX) is a copper company listed on US.
Kezar Life Sciences Inc (KZR) is a biotechnology company listed on NASDAQ.
Latest reported FCX revenue for 2026-06-30 was $13.26B. Net income was $1.86B. FCX currently screens at market cap $67.80B and trailing P/E 38.0.
Latest reported KZR revenue for 2024-12-31 was $0. Net income was -$83.7M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. KZR currently screens at market cap $53.9M.
FCX currently screens at market cap $67.80B and trailing P/E 38.0. KZR currently screens at market cap $53.9M.
Not investment advice. Open the FCX and KZR stock pages for the full models.
Not investment advice.